Page 52 - Corporate Earnings

After a dismal FY23, is the tide turning for mid, small-cap segments?

The S&P BSE Small-cap and Midcap indices have surged around 6 per cent and 4 per cent, respectively, as against a 2 per cent gain on S&P BSE Sensex so far in FY24.

Sensex ends 75pts up after choppy day, Nifty tops 17,750; ITC extends rally

CLOSING BELL: Among buzzing stocks, shares of RVNL were locked at 20 per cent upper circuit, RITES zoomed 9 per cent, and Texmaco Rail 7 per cent

Results preview: India Inc likely to report highly profitable Q4

Nifty50 firms may show 15.6% earnings growth, say brokerages; revenue growth to disappoint

Watchdogs or opportunists? Short sellers in focus after US bank crisis

Short interest in First Republic indeed increased as turmoil in the banking sector intensified, although measures vary

Wipro hits 52-week low amid revenue growth worries; down 38% in one year

The growth could be a challenge in Q1FY24, too, not just because of the cautious customer behavior but also due to the added issue of productivity concessions kicking in, says Nirmal Bang in a note.

Motilal Oswal sees 17% upside potential for top-100 stocks by market-cap

Adani Ports, Hindalco among stocks with 100 per cent 'Buy' rating by analysts.

Non-BFSI companies' net profits shrink sharply for second quarter

Banks account for most of incremental growth in India Inc earnings

ITC gains 3% a day ahead of turning ex-dividend; stock nears record high

With a modest 1 per cent increase in duty on cigarettes and improving outlook for FMCG and Hotels, brokerages think ITC is well positioned for a strong FY24.

Indian stock markets to continue underperforming EM peers: Morgan Stanley

Earlier in November 2022, Morgan Stanley had reiterated its stance on the Indian markets and said that the bull-run remained intact. Back then, they expected the Sensex to hit 80,000 levels by Dec '23

Finance cost weighs on India Inc's earnings in Q3; operating profit dips

Interest expense rises at fastest clip in 17 quarters in Q3

Sun Pharma Q3 net profit up 5.2% as sales grow in India, US markets

Company says specialty products will continue as growth driver, will scale up investment for it

Little to cheer for in Q3 early bird results; non-BFSI companies lag

In the slow lane: 2.5% rise in profit the least in 10 quarters

Stocks to Watch: Adani Ent, IndusInd Bank, Coal India, HUL, Asian Paints

Stocks to watch today: Metals and mining major Vedanta will acquire debt-laden power plant Meenakshi Energy for Rs 1,440 crore

Sensex ends 390 pts higher driven by HDFC twins, metals, Nifty above 18,150

Closing Bell: Within sectors, the Nifty metal index closed with most strength, up 1.5 per cent, followed by financials and pharma pockets, while PSB index slumped the most by over 1 per cent

Morgan Stanley profit beats on strength in wealth, trading units

UBS in a note said Morgan Stanley's fourth-quarter core trends were encouraging

Tata Metaliks Q3 results: Net profit falls 73% to Rs 9.48 crore

The company had posted a Rs 35.65 crore net profit in the year-ago period, according to a statement

Sensex ends 303 pts higher fueled by Infosys, ICICI Bank; Nifty near 17950

CLOSING BELL: Within sectors, barring consumer durables, PSB and Metal indices on the Nifty logged in most gains, up over 1 per cent each, followed by IT and financial pockets

HDFC Bank Q3: PAT may grow up to 20% YoY; margin, asset quality seen steady

Outlook on margin trajectory, asset quality in Agri/Unsecured book, and commentary around credit cards, traction in fee income, and the merger with HDFC will be the key monitorables, analysts said

Sensex ends 147pts lower at 59,958; Nifty50 below 17,900; RIL declines 2%

CLOSING BELL: Broader markets, too, were subdued in trade as Nifty SmallCap 100 and Nifty MidCap 100 indices slipped up to 0.2 per cent

Sensex, Nifty end choppy session flat; Airtel sinks 3%, HUL 2%, OMCs gain

Closing Bell: Sun Pharma claimed the top winner spot on the Sensex with a gain of 1.7 per cent on launching an anti-cancer drug Palbociclib in India for patients with advanced breast cancer